Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults

OBJECTIVE: Atopic dermatitis is a chronic, relapsing inflammatory skin disease characterized by intense pruritus, excoriations and limited therapies. Dupilumab, a monoclonal antibody against interleukin-4 receptor alpha, is a promising new treatment option for atopic dermatitis. We sought to systema...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Xu, Xinghua, Zheng, Yi, Zhang, Xin, He, Yanling, Li, Chengxin
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5752457/
https://ncbi.nlm.nih.gov/pubmed/29312544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22499
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky